CELESTICA INC (CLS) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:CLS • CA15101Q2071

307.53 USD
+12.64 (+4.29%)
At close: Feb 6, 2026
309.02 USD
+1.49 (+0.48%)
Pre-Market: 2/9/2026, 4:40:13 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to CLS. CLS was compared to 123 industry peers in the Electronic Equipment, Instruments & Components industry. CLS scores excellent on profitability, but there are some minor concerns on its financial health. CLS is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year CLS was profitable.
  • In the past year CLS had a positive cash flow from operations.
  • CLS had positive earnings in each of the past 5 years.
  • In the past 5 years CLS always reported a positive cash flow from operatings.
CLS Yearly Net Income VS EBIT VS OCF VS FCFCLS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

1.2 Ratios

  • CLS's Return On Assets of 11.54% is amongst the best of the industry. CLS outperforms 92.68% of its industry peers.
  • The Return On Equity of CLS (37.56%) is better than 96.75% of its industry peers.
  • The Return On Invested Capital of CLS (24.36%) is better than 99.19% of its industry peers.
Industry RankSector Rank
ROA 11.54%
ROE 37.56%
ROIC 24.36%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CLS Yearly ROA, ROE, ROICCLS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • Looking at the Profit Margin, with a value of 6.72%, CLS is in the better half of the industry, outperforming 73.98% of the companies in the same industry.
  • CLS's Profit Margin has improved in the last couple of years.
  • The Operating Margin of CLS (7.80%) is better than 72.36% of its industry peers.
  • CLS's Operating Margin has improved in the last couple of years.
  • With a Gross Margin value of 12.06%, CLS is not doing good in the industry: 75.61% of the companies in the same industry are doing better.
  • CLS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.8%
PM (TTM) 6.72%
GM 12.06%
OM growth 3Y32.38%
OM growth 5Y32.85%
PM growth 3Y49.6%
PM growth 5Y44.64%
GM growth 3Y11.17%
GM growth 5Y11.4%
CLS Yearly Profit, Operating, Gross MarginsCLS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CLS is creating value.
  • There is no outstanding debt for CLS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CLS Yearly Shares OutstandingCLS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
CLS Yearly Total Debt VS Total AssetsCLS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

  • The Debt to FCF ratio of CLS is 1.69, which is an excellent value as it means it would take CLS, only 1.69 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of CLS (1.69) is better than 80.49% of its industry peers.
  • A Debt/Equity ratio of 0.34 indicates that CLS is not too dependend on debt financing.
  • CLS's Debt to Equity ratio of 0.34 is in line compared to the rest of the industry. CLS outperforms 40.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 1.69
Altman-Z N/A
ROIC/WACC2.81
WACC8.67%
CLS Yearly LT Debt VS Equity VS FCFCLS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • CLS has a Current Ratio of 1.44. This is a normal value and indicates that CLS is financially healthy and should not expect problems in meeting its short term obligations.
  • CLS has a worse Current ratio (1.44) than 74.80% of its industry peers.
  • A Quick Ratio of 0.88 indicates that CLS may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.88, CLS is not doing good in the industry: 84.55% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 0.88
CLS Yearly Current Assets VS Current LiabilitesCLS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

9

3. Growth

3.1 Past

  • CLS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.59%, which is quite impressive.
  • CLS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 43.67% yearly.
  • The Revenue has grown by 28.46% in the past year. This is a very strong growth!
  • The Revenue has been growing by 16.61% on average over the past years. This is quite good.
EPS 1Y (TTM)54.59%
EPS 3Y46.94%
EPS 5Y43.67%
EPS Q2Q%70.27%
Revenue 1Y (TTM)28.46%
Revenue growth 3Y19.56%
Revenue growth 5Y16.61%
Sales Q2Q%43.57%

3.2 Future

  • The Earnings Per Share is expected to grow by 33.06% on average over the next years. This is a very strong growth
  • CLS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 28.15% yearly.
EPS Next Y38.59%
EPS Next 2Y37.93%
EPS Next 3Y33.06%
EPS Next 5YN/A
Revenue Next Year32.94%
Revenue Next 2Y32.93%
Revenue Next 3Y28.15%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CLS Yearly Revenue VS EstimatesCLS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B 20B 25B
CLS Yearly EPS VS EstimatesCLS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5 10

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 50.75 indicates a quite expensive valuation of CLS.
  • CLS's Price/Earnings is on the same level as the industry average.
  • The average S&P500 Price/Earnings ratio is at 27.93. CLS is valued rather expensively when compared to this.
  • Based on the Price/Forward Earnings ratio of 36.62, the valuation of CLS can be described as expensive.
  • CLS's Price/Forward Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.77, CLS is valued a bit more expensive.
Industry RankSector Rank
PE 50.75
Fwd PE 36.62
CLS Price Earnings VS Forward Price EarningsCLS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • CLS's Enterprise Value to EBITDA ratio is in line with the industry average.
  • CLS's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 77.19
EV/EBITDA 31.14
CLS Per share dataCLS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • CLS has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as CLS's earnings are expected to grow with 33.06% in the coming years.
PEG (NY)1.31
PEG (5Y)1.16
EPS Next 2Y37.93%
EPS Next 3Y33.06%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • CLS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CELESTICA INC

NYSE:CLS (2/6/2026, 8:25:28 PM)

Premarket: 309.02 +1.49 (+0.48%)

307.53

+12.64 (+4.29%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)02-01
Earnings (Next)04-22
Inst Owners73.66%
Inst Owner Change2.03%
Ins Owners0.59%
Ins Owner Change51.23%
Market Cap35.38B
Revenue(TTM)12.39B
Net Income(TTM)832.50M
Analysts81.11
Price Target270.8 (-11.94%)
Short Float %3.49%
Short Ratio1.37
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.66%
Min EPS beat(2)2.72%
Max EPS beat(2)6.6%
EPS beat(4)4
Avg EPS beat(4)6.92%
Min EPS beat(4)2.72%
Max EPS beat(4)11.71%
EPS beat(8)8
Avg EPS beat(8)8.61%
EPS beat(12)12
Avg EPS beat(12)8.72%
EPS beat(16)16
Avg EPS beat(16)8.39%
Revenue beat(2)2
Avg Revenue beat(2)3.27%
Min Revenue beat(2)1.55%
Max Revenue beat(2)5%
Revenue beat(4)4
Avg Revenue beat(4)4.11%
Min Revenue beat(4)1.55%
Max Revenue beat(4)7.4%
Revenue beat(8)7
Avg Revenue beat(8)3.46%
Revenue beat(12)11
Avg Revenue beat(12)3.05%
Revenue beat(16)15
Avg Revenue beat(16)3.51%
PT rev (1m)8.55%
PT rev (3m)39.81%
EPS NQ rev (1m)10.84%
EPS NQ rev (3m)11.62%
EPS NY rev (1m)0%
EPS NY rev (3m)0.76%
Revenue NQ rev (1m)9.38%
Revenue NQ rev (3m)11.41%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.61%
Valuation
Industry RankSector Rank
PE 50.75
Fwd PE 36.62
P/S 2.86
P/FCF 77.19
P/OCF 53.64
P/B 15.96
P/tB 21.88
EV/EBITDA 31.14
EPS(TTM)6.06
EY1.97%
EPS(NY)8.4
Fwd EY2.73%
FCF(TTM)3.98
FCFY1.3%
OCF(TTM)5.73
OCFY1.86%
SpS107.71
BVpS19.27
TBVpS14.06
PEG (NY)1.31
PEG (5Y)1.16
Graham Number51.25
Profitability
Industry RankSector Rank
ROA 11.54%
ROE 37.56%
ROCE 29.51%
ROIC 24.36%
ROICexc 29.78%
ROICexgc 38.37%
OM 7.8%
PM (TTM) 6.72%
GM 12.06%
FCFM 3.7%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y32.38%
OM growth 5Y32.85%
PM growth 3Y49.6%
PM growth 5Y44.64%
GM growth 3Y11.17%
GM growth 5Y11.4%
F-Score7
Asset Turnover1.72
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 1.69
Debt/EBITDA 0.66
Cap/Depr 114.51%
Cap/Sales 1.62%
Interest Coverage 17.86
Cash Conversion 57.76%
Profit Quality 55.05%
Current Ratio 1.44
Quick Ratio 0.88
Altman-Z N/A
F-Score7
WACC8.67%
ROIC/WACC2.81
Cap/Depr(3y)107.56%
Cap/Depr(5y)87.85%
Cap/Sales(3y)1.66%
Cap/Sales(5y)1.48%
Profit Quality(3y)69.38%
Profit Quality(5y)101.2%
High Growth Momentum
Growth
EPS 1Y (TTM)54.59%
EPS 3Y46.94%
EPS 5Y43.67%
EPS Q2Q%70.27%
EPS Next Y38.59%
EPS Next 2Y37.93%
EPS Next 3Y33.06%
EPS Next 5YN/A
Revenue 1Y (TTM)28.46%
Revenue growth 3Y19.56%
Revenue growth 5Y16.61%
Sales Q2Q%43.57%
Revenue Next Year32.94%
Revenue Next 2Y32.93%
Revenue Next 3Y28.15%
Revenue Next 5YN/A
EBIT growth 1Y69.46%
EBIT growth 3Y58.27%
EBIT growth 5Y54.91%
EBIT Next Year55.75%
EBIT Next 3Y35.82%
EBIT Next 5YN/A
FCF growth 1Y51.25%
FCF growth 3Y34.37%
FCF growth 5Y19.66%
OCF growth 1Y39.16%
OCF growth 3Y30.33%
OCF growth 5Y22.45%

CELESTICA INC / CLS FAQ

Can you provide the ChartMill fundamental rating for CELESTICA INC?

ChartMill assigns a fundamental rating of 6 / 10 to CLS.


What is the valuation status of CELESTICA INC (CLS) stock?

ChartMill assigns a valuation rating of 3 / 10 to CELESTICA INC (CLS). This can be considered as Overvalued.


What is the profitability of CLS stock?

CELESTICA INC (CLS) has a profitability rating of 7 / 10.


What is the valuation of CELESTICA INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CELESTICA INC (CLS) is 50.75 and the Price/Book (PB) ratio is 15.96.


How financially healthy is CELESTICA INC?

The financial health rating of CELESTICA INC (CLS) is 4 / 10.